pomalidomide has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, YH; Greig, NH; Hoffer, BJ; Huang, PS; Kim, DS; Lecca, D; Luo, W; Tsai, PY; Wang, JY; Yang, LY | 1 |
| Chiu, CC; Chou, SY; Greig, NH; Hoffer, BJ; Huang, YN; Luo, W; Luo, Y; Pick, CG; Tweedie, D; Wang, JY | 1 |
2 other study(ies) available for pomalidomide and Encephalopathy, Traumatic
| Article | Year |
|---|---|
3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury.
Topics: Animals; Brain Injuries, Traumatic; Cognition; Gliosis; Hippocampus; Immunologic Factors; Male; Memory; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Thalidomide | 2021 |
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.
Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; Encephalitis; Functional Laterality; Glial Fibrillary Acidic Protein; Immunologic Factors; Male; Motor Disorders; Nerve Degeneration; Phosphopyruvate Hydratase; Psychomotor Disorders; Rats; Rats, Sprague-Dawley; Somatosensory Disorders; Thalidomide | 2016 |